Nitta Kosaku
Department Other, Other Position |
|
Article types | Original article |
Language | English |
Peer review | Non peer reviewed |
Title | Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD). |
Journal | Formal name:Clinical and experimental nephrology Abbreviation:Clin Exp Nephrol ISSN code:(1437-7799)1342-1751(Linking) |
Volume, Issue, Page | 22(5),pp.1079-1087 |
Author and coauthor | Makabe Shiho, Mochizuki Toshio, Mitobe Michihiro, Aoyama Yumi, Kataoka Hiroshi, Tsuchiya Ken, Nitta Kosaku |
Authorship | Last author,Corresponding author |
Publication date | 2018/10 |
Summary | In patients with mild elevation of the serum liver enzyme, as is less than three times the upper limit of normal (ULN), resumption of tolvaptan may be considered after the serum liver enzyme levels return to normal range. |
DOI | 10.1007/s10157-018-1545-7 |
PMID | 29508162 |